CAMLINFINE — Camlin Fine Sciences Balance Sheet
0.000.00%
- IN₹34.35bn
- IN₹39.46bn
- IN₹16.67bn
- 77
- 23
- 71
- 61
Annual balance sheet for Camlin Fine Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,231 | 1,288 | 952 | 812 | 1,433 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,040 | 3,537 | 3,937 | 3,656 | 4,221 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,947 | 8,935 | 10,878 | 10,007 | 11,834 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,367 | 7,403 | 8,344 | 8,023 | 6,536 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 14,816 | 18,001 | 20,601 | 19,517 | 20,238 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,776 | 5,953 | 7,930 | 7,323 | 8,462 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 8,382 | 10,521 | 12,407 | 10,870 | 11,221 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 6,434 | 7,479 | 8,194 | 8,648 | 9,017 |
| Total Liabilities & Shareholders' Equity | 14,816 | 18,001 | 20,601 | 19,517 | 20,238 |
| Total Common Shares Outstanding |